Recruiting

Feasibility and Effectiveness of a Ring-Type Blood Pressure Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring in HFrEF

This study aims to evaluate the feasibility and diagnostic accuracy of the CART-BP ring-type wearable blood pressure monitoring device in comparison with 24-hour ambulatory blood pressure monitoring (ABPM) in patients with heart failure with reduced ejection fraction (HFrEF, LVEF ≤ 40%). As a multi-center, prospective, exploratory study, 100 patients will be enrolled at two tertiary hospitals in South Korea. The agreement between the two devices in 24-hour mean, daytime, and nighttime blood pressure measurements…

I'm interested View official listing
ClinicalTrials.gov IDNCT07626879
PhaseNot Applicable
Enrollment100
SponsorKeimyung University Dongsan Medical Center
Age19 Years and older
SexALL
I'm interested View official listing

Conditions studied

Heart Failure With Reduced Ejection Fraction; Hypertension

About this study

This study aims to evaluate the feasibility and diagnostic accuracy of the CART-BP ring-type wearable blood pressure monitoring device in comparison with 24-hour ambulatory blood pressure monitoring (ABPM) in patients with heart failure with reduced ejection fraction (HFrEF, LVEF ≤ 40%). As a multi-center, prospective, exploratory study, 100 patients will be enrolled at two tertiary hospitals in South Korea. The agreement between the two devices in 24-hour mean, daytime, and nighttime blood pressure measurements will be assessed per ISO 81060-2:2018 criteria.

Primary outcomes

Eligibility information

Inclusion Criteria: 1. Age ≥ 19 years (male or female) 2. Diagnosed with heart failure and currently under treatment 3. Left ventricular ejection fraction (LVEF) ≤ 40% confirmed by echocardiography performed within 1 year prior to enrollment 4. Able to undergo both 24-hour ambulatory blood pressure monitoring and ring-type blood pressure measurement 5. Voluntarily provided written informed consent to participate in this clinical study Exclusion Criteria: 1. Office blood pressure: SBP \< 90 mmHg, or DBP \< 50 mmHg, or SBP \> 180 mmHg, or DBP \> 100 mmHg 2. Unable to perform 24-hour ambulatory blood pressure monitoring 3. Unable to wear or use the ring-type blood pressure device 4. Variability in three consecutive resting cuff blood pressure measurements ≥ 20 mmHg (SBP) or ≥ 10 mmHg (DBP) 5. Insufficient valid ABPM readings: \< 25 daytime or \< 12 nighttime measurements per ESH criteria; or \< 25 daytime or \< 12 nighttime valid readings from the ring-type device 6. Pregnant, suspected pregnancy, or breastfeeding 7. Judged by the investigator to be legally or mentally unfit to participate in the clinical study

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-05.